10 Mar 2021 16:30
RSA Insurance Group plc
("the Company")
Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")
Ordinary Shares of £1.00 each
10 March 2021
The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Ordinary Shares").
On 8 March 2021 the Company granted the following Conditional Awards over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) to the following PDMRs at nil cost:
Name | No. of Bonus Deferral Shares Awarded |
Stephen Hester | 124,441 |
Charlotte Jones | 60,212 |
Scott Egan | 47,195 |
Martin Thompson | 50,478 |
Nathan Williams | 31,295 |
Karen Caddick | 27,361 |
Ralph Daals | 15,389 |
Charlotte Heiss | 15,691 |
William McDonnell | 21,099 |
Ken Norgrove | 9,538 - vesting date 10 March 2021 23,846 - vesting date 8 March 2025 |
Bonus Deferral Shares:
Awards of Bonus Deferral Shares are granted as part of the Annual Bonus award. In line with regulatory requirements in Scandinavia, 9,538 of the shares subject to the award granted to Ken Norgrove vested immediately on 10 March 2021. Under normal circumstances and in line with regulatory requirements in Scandinavia, the balance of 23,846 shares will vest on 8 March 2025. A six-month holding period is applicable to these share awards, from the relevant vesting date.
Under normal circumstances, Awards of Bonus Deferral Shares will vest on 8 March 2024 (except for Ken Norgrove), subject to the rules of the PSP and the provisions of the Company's approved Remuneration Policy.
On 10 March 2021 the nil cost Conditional Awards over Shares granted on 8 March 2021 under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMR vested as shown in the table below
Name | No. of Bonus Deferral Shares Vested | No. of Shares sold to cover statutory deductions |
Ken Norgrove | 9,538 | 4,975 |
The forms required under the EU Market Abuse Regulation follow.
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Stephen Hester | ||||
b) | Position / status | Group Chief Executive | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
124,441 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Charlotte Jones | ||||
b) | Position / status | Group Chief Financial Officer | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
60,212 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Scott Egan | ||||
b) | Position / status | CEO, UK and International | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
47,195 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Martin Thompson | ||||
b) | Position / status | CEO, Canada | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
50,478 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Nathan Williams | ||||
b) | Position / status | Group Underwriting Director | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
31,295 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Karen Caddick | ||||
b) | Position / status | Group and UK&I HR Director | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
27,361 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Ralph Daals | ||||
b) | Position / status | Group Chief Auditor | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
15,389 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | Charlotte Heiss | ||||
b) | Position / status | Group General Counsel and Company Secretary | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
15,691 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | |||||
a) | Name | William McDonnell | ||||
b) | Position / status | Group Chief Risk Officer | ||||
c) | Initial notification / amendment | Initial Notification | ||||
2. | Details of the issuer | |||||
a) | Name | RSA Insurance Group plc | ||||
b) | LEI | 549300HOGQ7E0TY86138 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | ||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
21,099 NIL | ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | XLON London Stock Exchange
| ||||
1. | Details of PDMR / Persons Closely Associated ("PCA") | ||||||||
a) | Name | Ken Norgrove | |||||||
b) | Position / status | CEO, RSA Scandinavia | |||||||
c) | Initial notification / amendment | Initial Notification | |||||||
2. | Details of the issuer | ||||||||
a) | Name | RSA Insurance Group plc | |||||||
b) | LEI | 549300HOGQ7E0TY86138 | |||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost with a vesting date of 8 March 2025. | |||||||
c) | Price(s) and volume(s) |
| |||||||
d) | Aggregated information - Aggregated volume - Price |
23,846 NIL | |||||||
e) | Date of the transaction | 2021-03-08 | |||||||
f) | Place of the transaction | XLON London Stock Exchange
| |||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 | |||||||
b) | Nature of the transaction | Award of Deferral Bonus shares over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost with a vesting date of 10 March 2021. | |||||||
c) | Price(s) and volume(s) |
| |||||||
d) | Aggregated information - Aggregated volume - Price |
9,538 NIL | |||||||
e) | Date of the transaction | 2021-03-08 | |||||||
f) | Place of the transaction | XLON London Stock Exchange
| |||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| |||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 |
| ||||||
b) | Nature of the transaction | Vesting of Bonus Deferral Share award granted on 10 March 2021 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares (less any sold to cover statutory deductions) are subject to a six-month holding period which ends on 10 September 2021. |
| ||||||
c) | Price(s) and volume(s) |
|
| ||||||
d) | Aggregated information - Aggregated volume - Price |
9,538
Nil |
| ||||||
e) | Date of the transaction | 2021-03-10 |
| ||||||
f) | Place of the transaction | XLON London Stock Exchange |
| ||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| |||||||
a) | Description of the financial instrument | Ordinary Shares of £1 each ISIN: GB00BKKMKR23 |
| ||||||
b) | Nature of the transaction | Sale of shares to cover statutory deductions on share awards vested on 10 March 2021 under the RSA Performance Share Plan 2014. |
| ||||||
c) | Price(s) and volume(s) |
|
| ||||||
d) | Aggregated information - Aggregated volume - Price |
4,975 GBP 6.78 |
| ||||||
e) | Date of the transaction | 2021-03-10 |
| ||||||
f) | Place of the transaction | XLON London Stock Exchange |
| ||||||
Enquiries to:
Christopher Smyth, Deputy Group Company Secretary
RSA Insurance Group plc
Tel: +44 (0) 20 7111 7000